A male Covid-19 convalescent plasma donor with long existence of SARS-Cov-2 antibodies: a case report

A male Covid-19 convalescent plasma donor with long existence of SARS-Cov-2 antibodies: a case report

Covid-19 Convalescent Plasma (CCP) was one of alternative therapy for Covid-19 patients. The use of convalescent plasma as an adjunct therapy must consider its efficacy, benefits, and risk, both for the patient and the donor. Convalescent Plasma was produced from purified human plasma. Convalescent...

Full description

Bibliographic Details
Main Authors:	Teguh Triyono, Usi Sukorini, Andri Christianalusi, Sri Mulatsih, Hans Vrielink
Format:	Article
Language:	English
Published:	Faculty of Medicine 2023-08-01
Series:	JKKI (Jurnal Kedokteran dan Kesehatan Indonesia)
Online Access:	https://jurnal.uii.ac.id/JKKI/article/view/25589

Similar Items

Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions
by: Tatiana Carvalho de Souza Bonetti, et al.
Published: (2021-08-01)

Anti-SARS-CoV-2 antibody responses in convalescent plasma donors with varying severity of COVID-19 illness
by: Grujić Jasmina, et al.
Published: (2022-01-01)

Turnaround time for the provision of packed red cells (PRC) and factors affecting their achievements in the Blood Transfusion Unit of Dr. Sardjito General Hospital, Yogyakarta
by: Surawijaya Bakhtiar Kaslam, et al.
Published: (2023-07-01)

Increased Risk of Tumor Necrosis Factor-Alpha Levels in Adult Patients with Malignancy Receiving Non-Leucodepleted Packed Red Cells Transfusion
by: Triyono, Teguh, et al.
Published: (2022)

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization
by: Harvala, H, et al.
Published: (2022)

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection
by: Song Mu, et al.
Published: (2022-10-01)

P1622: ANTIPHOSPHOLIPID ANTIBODIES IN CONVALESCENT PLASMA OF DONORS RECOVERED FROM MILD COVID-19
by: D. Blickstein, et al.
Published: (2022-06-01)

Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates
by: Günalp Uzun, et al.
Published: (2023-06-01)

Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
by: Evangelos Terpos, et al.
Published: (2020-11-01)

Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma
by: Samantha K Davis, et al.
Published: (2022-01-01)

Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
by: Maddalena Marconato, et al.
Published: (2022-06-01)

Characteristics and Motivational Factors of Whole Blood and Convalescent Plasma Donors during the SARS-CoV-2 Pandemic in Israel
by: Eilat Shinar, et al.
Published: (2024-03-01)

SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability
by: Sandra Laner-Plamberger, et al.
Published: (2022-10-01)

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
by: Latha Dulipsingh, et al.
Published: (2023-06-01)

Penelaahan penetapan aktivitas faktor VIII dan IX plasma dengan metode APTT substitusi manual
by: , SUKORINI, Usi, et al.
Published: (1995)

Penelaahan penetapan aktivitas faktor VIII dan IX plasma dengan metode APTT substitusi manual
by: , SUKORINI, Usi, et al.
Published: (1995)

Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants
by: Kiyoto Tsuchiya, et al.
Published: (2023-01-01)

Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.
by: Sharada Saraf, et al.
Published: (2022-01-01)

Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies
by: van Griensven, J, et al.
Published: (2016)

Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration
by: Wesley V Cain, et al.
Published: (2022-01-01)

Multistep screening and selection of COVID‐19 convalescent plasma donors at the early stage of the SARS‐CoV‐2 pandemic: A retrospective analysis
by: Andreas M. Brosig, et al.
Published: (2022-09-01)

Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS‐CoV‐2
by: Valk, SJ, et al.
Published: (2021)

Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
by: David J. Sullivan, et al.
Published: (2022-10-01)

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
by: Nitin Hingankar, et al.
Published: (2022-04-01)

Investigation of SARS-CoV-2 Variants and Their Effect on SARS-CoV-2 Monoclonal Antibodies, Convalescent and Vaccine Plasma by a Novel Web Tool
by: Ayse Arikan, et al.
Published: (2022-11-01)

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
by: Daniele Focosi, et al.
Published: (2021-06-01)

Neutralizing antibodies in convalescent patients
by: Uhl, LFK, et al.
Published: (2020)

Association Between COVID-19 and ABO Blood Groups: An Analysis on Convalescent Plasma Donors in Turkey
by: Mustafa Yilmaz, et al.
Published: (2021-06-01)

Antibody False Positivity Among COVID-19 Convalescent Plasma Donors: A Comparative Study from the Turkish Red Crescent Blood Center
by: Levent Hayat, et al.
Published: (2021-11-01)

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
by: Zhou, D, et al.
Published: (2020)

Longitudinal anti-SARS-CoV-2 antibody immune response in acute and convalescent patients
by: Horacio Pérez-Juárez, et al.
Published: (2023-09-01)

Dynamics of Cytokine, SARS-CoV-2-Specific IgG, and Neutralizing Antibody Levels in COVID-19 Patients Treated with Convalescent Plasma
by: Pornpitra Pratedrat, et al.
Published: (2023-08-01)

Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection.
by: Natasha M Clark, et al.
Published: (2022-01-01)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed Moubarak, et al.
Published: (2021-07-01)

Clinical efficacy and safety of convalescent plasma therapy for patients with SARS-CoV-2 infection
by: D. V. Lavrenchuk, et al.
Published: (2022-04-01)

Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection
by: Ioannis V. Kostopoulos, et al.
Published: (2021-03-01)

Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection
by: Nikolaos Orologas-Stavrou, et al.
Published: (2020-12-01)

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
by: Romain Rouet, et al.
Published: (2023-02-01)

Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers
by: Christine Bäuerl, et al.
Published: (2023-06-01)

Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients
by: Ngai Sze Wong, et al.
Published: (2022-05-01)